SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-010854
Filing Date
2021-01-19
Accepted
2021-01-19 07:57:54
Documents
12
Period of Report
2021-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d109420d8k.htm   iXBRL 8-K 38774
  Complete submission text file 0001193125-21-010854.txt   165942

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrus-20210118.xsd EX-101.SCH 3057
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20210118_lab.xml EX-101.LAB 18054
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20210118_pre.xml EX-101.PRE 11372
5 EXTRACTED XBRL INSTANCE DOCUMENT d109420d8k_htm.xml XML 3384
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 21533961
SIC: 2834 Pharmaceutical Preparations